Brian C. Walker
Brian C. Walker's purchase track record
Brian C. Walker has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/28/2026 | HBNC | $24K | +13.5% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Goldman Sachs downgrades Gentex to Sell, UBS cuts target. Goldman Sachs downgraded Gentex to Sell and lowered its price target to $20, while UBS maintained a Neutral rating but cut its target to $24. These moves reflect growing concerns about the automotive sector, with one analyst noting the stock is cheap but wary of industry headwinds. The stock currently trades near its 52-week low, with an average analyst target of $27.28.
Transaction History
| HBNC | ▲ Buy | Grant | 306 | $6K | 8/26/2026 | View on chart |
| GNTX | ▲ Buy | Grant | 5,626 | $0 | 5/21/2026 | View on chart |
| GNTX | ▼ Sell | Open Market | 5,939 | $136K | 5/15/2026 | View on chart |
| HBNC | ▲ Buy | Open Market | 1,306 | $24K | 4/28/2026 | View on chart |
| HBNC | ▲ Buy | Grant | 2,662 | $45K | 2/27/2026 | View on chart |
| HBNC | ▲ Buy | Grant | 331 | $5K | 6/9/2025 | View on chart |
| GNTX | ▲ Buy | Grant | 5,939 | $0 | 5/15/2025 | View on chart |
| GNTX | ▲ Buy | Grant | 3,764 | $0 | 5/16/2024 | View on chart |
| GNTX | ▲ Buy | Grant | 4,716 | $0 | 5/18/2023 | View on chart |
| GNTX | ▲ Buy | Grant | 3,397 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
HBNC Named in Higher-For-Longer Rate Outlook
Horizon Bancorp was included in a recent list of US bank stocks that may benefit if interest rates remain elevated. The article suggests that higher rates can support net interest income for regional banks. This context aligns with the stock's 5.74% dividend yield and current trading levels near its 52-week range.
HBNC Named in Higher-For-Longer Rate Outlook. Horizon Bancorp was included in a recent list of US bank stocks that may benefit if interest rates remain elevated. The article suggests that higher rates can support net interest income for regional banks. This context aligns with the stock's 5.74% dividend yield and current trading levels near its 52-week range.